Direct answer: Most people are eligible for GLP-1 therapy, but specific medical histories and conditions are common GLP-1 contraindications disqualifiers that may prevent a safe prescription. A clinician review and a medical assessment are required to determine whether you may be eligible for treatment in FL or NY.
Ready to find out if you qualify? Start Free Assessment — No payment required
What does "disqualify" mean for GLP-1 therapy?
Being disqualified means a provider may determine the risks of GLP-1 medication outweigh the benefits based on your medical history or current health status. Disqualification is not automatic for every condition; instead, these factors help clinicians decide whether to prescribe, recommend alternative approaches, or refer you for further evaluation.
Providers evaluate candidates through a formal review that includes medical history, current medications, and lab values. If you want to learn more about the service model and telehealth options, see our GLP-1 program overview at /glp1-weight-loss-program and /weight-loss-online.
Common medical contraindications disqualifying patients
The most widely recognized GLP-1 contraindications disqualifiers include a personal or strong family history of certain thyroid cancers and known hypersensitivity to the medication. Specifically, a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) is considered an absolute contraindication for some GLP-1 agonists.
Other important disqualifiers can include pregnancy or active breastfeeding, where GLP-1s are not recommended due to potential risks to the fetus or infant. If you are pregnant, planning pregnancy, or breastfeeding, discuss non-medication options with your provider and revisit eligibility after pregnancy.
Conditions that may potentially disqualify or require caution
A history of severe pancreatitis or recurrent pancreatitis is frequently flagged during evaluation because GLP-1 therapies have been associated with pancreatic inflammation in some reports. While evidence is mixed, many providers treat prior pancreatitis as a potential disqualifier and will consider alternatives or additional monitoring.
Severe gastrointestinal disorders like gastroparesis or chronic severe nausea and vomiting may also lead clinicians to recommend against GLP-1s, since these medications can slow gastric emptying and potentially worsen symptoms. Kidney or liver impairment may require dose adjustments or alternative therapies; a provider review will determine if treatment is appropriate.
Medication interactions and coexisting treatments
Certain medications and combinations can increase risks when paired with GLP-1 therapy. For example, combining GLP-1 agonists with insulin or insulin secretagogues can increase the chance of hypoglycemia unless doses are adjusted. Your provider will review all prescriptions and over-the-counter products you use to identify potential interactions.
Anticoagulants, certain psychiatric medications, and therapies with narrow therapeutic windows may require closer monitoring when starting GLP-1 treatment. Always disclose current medications during your consultation so clinicians can assess whether you may be eligible or need a modified plan.
Who else might be evaluated carefully before prescribing?
Patients with unstable cardiovascular disease, recent acute illness, or those with a history of severe allergic reactions may undergo extra screening. A history of acute gallbladder disease or rapid weight loss that led to gallstones could prompt a provider to discuss risks and symptom monitoring strategies.
Young adults, adolescents, and individuals with eating disorders are typically reviewed with caution; GLP-1 medications are not appropriate for everyone. If you have active eating disorder behaviors, a provider may consider alternative treatments and coordinate care with mental health professionals.
Why Provider Review Matters
A provider-reviewed telehealth approach helps match the right treatment to the right patient and reduces the chance of prescribing when risks outweigh benefits. Clinicians evaluate GLP-1 contraindications disqualifiers in context, looking at medical history, labs, current symptoms, and reproductive plans to determine eligibility.
At EdenRx we follow a documented review process so that decisions are individualized and medically appropriate. To understand how initial screening works and what questions you will be asked, visit /who-qualifies-for-weight-loss-medication and begin a confidential review with our team at /assessment.
Built from Eden Med Spa — real patients, real treatments.
Ready to find out if you qualify? Start Free Assessment — No payment required
Frequently Asked Questions
Q: Are thyroid problems always a disqualifier for GLP-1 medications? A: A general thyroid disorder is not automatically disqualifying, but a personal or family history of medullary thyroid carcinoma (MTC) or MEN2 is considered a contraindication for some GLP-1 agonists. Providers will review your specific thyroid history and may request tests or specialist input.
Q: Can I take GLP-1 medication if I had pancreatitis in the past? A: A history of severe or recurrent pancreatitis often prompts caution and may disqualify you from GLP-1 therapy. Providers assess the severity and timing of past pancreatitis and may recommend alternative treatments or further monitoring.
Q: Are pregnant or breastfeeding people eligible? A: GLP-1 medications are typically not recommended during pregnancy or while breastfeeding. If you are planning a pregnancy or are pregnant, your provider will discuss safer alternatives and revisit eligibility after pregnancy.
Q: What if I am on insulin or other diabetes drugs? A: Combining GLP-1s with insulin or sulfonylureas requires careful dose adjustments to reduce hypoglycemia risk. A provider review will determine whether you may be eligible and how to safely coordinate medications.
Q: How do you determine eligibility during telehealth visits? A: Our clinicians review your health history, medications, and relevant labs via secure telehealth. If additional testing or specialist input is needed, we will guide you through the steps. Start with a confidential screening at /assessment.
Q: Do cost and program options affect eligibility? A: Cost does not determine medical eligibility, but understanding pricing and program structure helps patients plan. Learn more about our program options at /programs and view transparent costs at /pricing.
Conclusion
GLP-1 contraindications disqualifiers are specific medical histories and conditions that may prevent safe use of GLP-1 medications. A provider review is essential to evaluate risks and benefits, especially for people with thyroid cancer history, prior pancreatitis, pregnancy, or severe gastrointestinal disorders. If you live in Florida or New York and want to explore whether you may be eligible, start a confidential assessment to speak with our clinician team.
Ready to see if you qualify? Start Free Assessment — No payment required
If you want a deeper look at program options and how our telehealth pathways work, visit /glp1-weight-loss-program and /weight-loss-online for details on next steps and support.
